Author

J. Bond

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Animal Behavior & Cognition· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 5 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Assay:behavioral assay· 1

Frequent Co-Authors

A. Beery· 1 shared A. K. Kheirallah· 1 shared A. Krzywon· 1 shared A. Mandoli· 1 shared A. P. Droop· 1 shared A. Roggy· 1 shared A. Seelke· 1 shared A. Trinquand· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 5 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperAnimal Behavior & Cognition

A. Beery

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Loss of Polycomb Repressive Complex 2 function causes asparaginase resistance in T-acute lymphoblastic leukemia through decreased WNT pathway activity

T. Lefeivre, C. Tudose, T.-I. Grosu, L. Jones, T. Leon, K. Wynne, G. Oliviero, O. Smith, A. Trinquand, M. Mansour, C. Ryan, J. Bond

The paper identifies that PRC2 loss in T-ALL reduces WNT pathway activity, leading to asparaginase resistance, which can be overcome by proteasome inhibition.

bioRxiv · Aug 4, 2023 · PreprintCancer Biology

Oxytocin receptor is not required for social attachment in prairie voles

K. M. Berendzen, R. Sharma, M. Alvarado, Y. Wei, F. D. Rogers, A. Seelke, T. C. Simmons, J. Bond, R. D. Larios, M. Sherman, S. Parthasarathy, I. Espineda, J. R. Knoedler, A. Beery, K. L. Bales, , D. S. Manoli

This study shows that oxytocin receptor signaling is not required for social attachment, parturition, or parental behavior in prairie voles.

bioRxiv · Jul 22, 2022Animal Behavior & Cognition

Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies.

A. V. R. Lake, C. E. L. Smith, S. Natarajan, B. Basu, S. K. Best, T. Stevenson, R. Trowbridge, S. N. Grellscheid, J. Bond, R. Foster, C. A. Johnson

The paper identifies ROCK2 as a therapeutic target for ciliopathies through drug and siRNA screens, showing ROCK2 inhibitors could treat cystic kidney disease.

bioRxiv · Nov 26, 2020Cell Biology

A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis

J. Bond, A. Krzywon, L. Lhermitte, C. Roumier, A. Roggy, M. Belhocine, A. K. Kheirallah, P. Villarese, G. Hypolite, F. Garnache-Ottou, S. Castaigne, N. Boissel, V. Asnafi, C. Preudhomme, H. Dombret, , E. Macintyre

The paper identifies a transcriptomic continuum of differentiation arrest in acute leukemias, finding that myeloid/T-lymphoid interface leukemias (IALs) correlate with poor prognosis in AML.

bioRxiv · Dec 10, 2019Cancer Biology

A high-content screen profiles cytotoxic microRNAs in pediatric and adult glioblastoma cells and identifies miR-1300 as a potent inducer of cytokinesis failure

M. Boissinot, H. King, M. Adams, J. Higgins, T. A. Ward, L. P. Steele, D. Tams, R. Morton, E. Polson, B. da Silva, A. P. Droop, J. L. Hayes, H. Martin, P. Laslo, E. E. Morrison, , S. C. Short

This study identifies miR-1300 as a potent cytotoxic microRNA in glioblastoma cells, causing cytokinesis failure and apoptosis, with potential therapeutic applications.

bioRxiv · Oct 1, 2019 · PreprintCancer Biology

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1

G. Yi, A. Mandoli, L. Jussen, E. Tijchon, G. Cordonnier, M. Hansen, B. Kim, L. N. Nguyen, P. Jansen, M. Vermeulen, E. van den Akker, J. Bond, J. H. A. Martens

This study shows that the CBFβ-MYH11 fusion protein inhibits megakaryocyte differentiation by disrupting the GATA2 and KLF1 gene program in inv(16) AML cells.

bioRxiv · Oct 29, 2018Cancer Biology